Histone Deacetylases and Histone Deacetylase Inhibitors: Molecular Mechanisms of Action in Various Cancers.

Adv Biomed Res · 2019 · PMC6839273 · PMID 31737580

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The other studies have shown strong expression of HDAC1, HDAC2, and HDAC3 in the prostate cancer and the expression of HDAC2 as a highly significant prognostic value.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.